279 related articles for article (PubMed ID: 23960082)
1. Tyrosine phosphorylation on spleen tyrosine kinase (Syk) is differentially regulated in human and murine platelets by protein kinase C isoforms.
Buitrago L; Bhavanasi D; Dangelmaier C; Manne BK; Badolia R; Borgognone A; Tsygankov AY; McKenzie SE; Kunapuli SP
J Biol Chem; 2013 Oct; 288(40):29160-9. PubMed ID: 23960082
[TBL] [Abstract][Full Text] [Related]
2. Feedback Regulation of Syk by Protein Kinase C in Human Platelets.
Makhoul S; Dorschel S; Gambaryan S; Walter U; Jurk K
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31881809
[TBL] [Abstract][Full Text] [Related]
3. Akt and mitogen-activated protein kinase enhance C-type lectin-like receptor 2-mediated platelet activation by inhibition of glycogen synthase kinase 3α/β.
Moroi AJ; Watson SP
J Thromb Haemost; 2015 Jun; 13(6):1139-50. PubMed ID: 25858425
[TBL] [Abstract][Full Text] [Related]
4. The novel Syk inhibitor R406 reveals mechanistic differences in the initiation of GPVI and CLEC-2 signaling in platelets.
Spalton JC; Mori J; Pollitt AY; Hughes CE; Eble JA; Watson SP
J Thromb Haemost; 2009 Jul; 7(7):1192-9. PubMed ID: 19422460
[TBL] [Abstract][Full Text] [Related]
5. Distinct pathways regulate Syk protein activation downstream of immune tyrosine activation motif (ITAM) and hemITAM receptors in platelets.
Manne BK; Badolia R; Dangelmaier C; Eble JA; Ellmeier W; Kahn M; Kunapuli SP
J Biol Chem; 2015 May; 290(18):11557-68. PubMed ID: 25767114
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of [3-(1-methyl-1H-indol-3-yl-methylene)-2-oxo-2, 3-dihydro-1H-indole-5-sulfonamide] (OXSI-2), as a Syk-selective inhibitor in platelets.
Bhavaraju K; Kim S; Daniel JL; Kunapuli SP
Eur J Pharmacol; 2008 Feb; 580(3):285-90. PubMed ID: 18068154
[TBL] [Abstract][Full Text] [Related]
7. Differential Regulation of GPVI-Induced Btk and Syk Activation by PKC, PKA and PP2A in Human Platelets.
Zhang P; Solari FA; Heemskerk JWM; Kuijpers MJE; Sickmann A; Walter U; Jurk K
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175486
[TBL] [Abstract][Full Text] [Related]
8. A critical role for the regulation of Syk from agglutination to aggregation in human platelets.
Shih CH; Chiang TB; Wang WJ
Biochem Biophys Res Commun; 2014 Jan; 443(2):580-5. PubMed ID: 24326074
[TBL] [Abstract][Full Text] [Related]
9. The alpha2beta1 integrin is a necessary co-receptor for collagen-induced activation of Syk and the subsequent phosphorylation of phospholipase Cgamma2 in platelets.
Keely PJ; Parise LV
J Biol Chem; 1996 Oct; 271(43):26668-76. PubMed ID: 8900143
[TBL] [Abstract][Full Text] [Related]
10. G
Badolia R; Inamdar V; Manne BK; Dangelmaier C; Eble JA; Kunapuli SP
J Biol Chem; 2017 Sep; 292(35):14516-14531. PubMed ID: 28705934
[TBL] [Abstract][Full Text] [Related]
11. Role of Fc receptor gamma-chain in platelet glycoprotein Ib-mediated signaling.
Wu Y; Suzuki-Inoue K; Satoh K; Asazuma N; Yatomi Y; Berndt MC; Ozaki Y
Blood; 2001 Jun; 97(12):3836-45. PubMed ID: 11389024
[TBL] [Abstract][Full Text] [Related]
12. cAMP- and cGMP-elevating agents inhibit GPIbα-mediated aggregation but not GPIbα-stimulated Syk activation in human platelets.
Makhoul S; Trabold K; Gambaryan S; Tenzer S; Pillitteri D; Walter U; Jurk K
Cell Commun Signal; 2019 Sep; 17(1):122. PubMed ID: 31519182
[TBL] [Abstract][Full Text] [Related]
13. Functional interaction of protein kinase Calpha with the tyrosine kinases Syk and Src in human platelets.
Pula G; Crosby D; Baker J; Poole AW
J Biol Chem; 2005 Feb; 280(8):7194-205. PubMed ID: 15583006
[TBL] [Abstract][Full Text] [Related]
14. Aggretin, a heterodimeric C-type lectin from Calloselasma rhodostoma (Malayan pit viper), stimulates platelets by binding to α2β1 integrin and glycoprotein Ib, activating Syk and phospholipase Cγ 2, but does not involve the glycoprotein VI/Fc receptor γ chain collagen receptor.
Navdaev A; Clemetson JM; Polgar J; Kehrel BE; Glauner M; Magnenat E; Wells TN; Clemetson KJ
J Biol Chem; 2001 Jun; 276(24):20882-9. PubMed ID: 11287424
[TBL] [Abstract][Full Text] [Related]
15. Cyclic AMP-insensitive activation of c-Src and Syk protein-tyrosine kinases through platelet membrane glycoprotein VI.
Ichinohe T; Takayama H; Ezumi Y; Yanagi S; Yamamura H; Okuma M
J Biol Chem; 1995 Nov; 270(47):28029-36. PubMed ID: 7499287
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Src but not Syk causes weak reversal of GPVI-mediated platelet aggregation measured by light transmission aggregometry.
Cheung HYF; Moran LA; Sickmann A; Heemskerk JWM; Garcia Á; Watson SP
Platelets; 2022 Nov; 33(8):1293-1300. PubMed ID: 35535424
[TBL] [Abstract][Full Text] [Related]
17. Collagen-stimulated activation of Syk but not c-Src is severely compromised in human platelets lacking membrane glycoprotein VI.
Ichinohe T; Takayama H; Ezumi Y; Arai M; Yamamoto N; Takahashi H; Okuma M
J Biol Chem; 1997 Jan; 272(1):63-8. PubMed ID: 8995228
[TBL] [Abstract][Full Text] [Related]
18. A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2.
Suzuki-Inoue K; Fuller GL; García A; Eble JA; Pöhlmann S; Inoue O; Gartner TK; Hughan SC; Pearce AC; Laing GD; Theakston RD; Schweighoffer E; Zitzmann N; Morita T; Tybulewicz VL; Ozaki Y; Watson SP
Blood; 2006 Jan; 107(2):542-9. PubMed ID: 16174766
[TBL] [Abstract][Full Text] [Related]
19. Rapid ubiquitination of Syk following GPVI activation in platelets.
Dangelmaier CA; Quinter PG; Jin J; Tsygankov AY; Kunapuli SP; Daniel JL
Blood; 2005 May; 105(10):3918-24. PubMed ID: 15701717
[TBL] [Abstract][Full Text] [Related]
20. G6b-B inhibits constitutive and agonist-induced signaling by glycoprotein VI and CLEC-2.
Mori J; Pearce AC; Spalton JC; Grygielska B; Eble JA; Tomlinson MG; Senis YA; Watson SP
J Biol Chem; 2008 Dec; 283(51):35419-27. PubMed ID: 18955485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
